Learn more about Amarin's first commercialized product

We operate or partner to make our medicine available across the globe. To report an adverse event or a product complaint, or to request information about our product, please visit our Contact Us page. VASCEPA®/VAZKEPA® (icosapent ethyl) is a prescription-only medicine. This means it can only be prescribed by a suitably qualified healthcare professional who can assess its appropriateness for individual patients. Healthcare professionals and patients are asked to report any suspected adverse reactions.

Learn More About Our Product

Learn more about Amarin's product and how it reflects the work of our dedicated team, together with the contributions from many healthcare professionals and investors.

By clicking the links below you are certifying that you are a US resident.

redirect 
 

Download EU SmPC

Summary of Product Characteristics. This information is intended for EU residents only.

Download

Download U.S. PI

Full Prescribing Information. This information is intended for U.S. residents only.

Download

What To Do If You Experience Side Effects While Taking An Amarin Medicine

If you are taking a prescribed Amarin medicine and experience any side effects, you should immediately report these to your doctor, to another healthcare professional (such as a nurse or caretaker), or via the national reporting system. Please connect with us using the link below.

Our Science

Putting cardiovascular health at the forefront of disease management

  1. Ganda OP, Bhatt DL, Mason RP, Miller M, Boden WE. Unmet need for adjunctive dyslipidemia therapy in hypertriglyceridemia management. J Am Coll Cardiol. 2018;72(3):330-343.
  2. Miller M, Tokgozoglu L, Parhofer KG, et al. Icosapent ethyl for reduction of persistent cardiovascular risk: a critical review of major medical society guidelines and statements. Expert Rev Cardiovasc Ther. 2022;20(8):609-625
Amarin Logo
You are about to leave the Amarincorp.com website
You have selected a link that will take you away from the amarincorp.com website. Amarin is not responsible for the content of the alternate website. Privacy and security policies of the alternate website may differ from those practiced by Amarin.

By clicking on the continue button below, you acknowledge the previous statement and will be taken to the linked site. If you want to remain at this site, select the cancel button. Thank you.